Navigation Links
CryoCath Announces Fiscal 2008 Second Quarter Results
Date:5/12/2008

------------------------

-------------------------------------------------------------------------

Weighted average

number of common

shares 38,245,559 37,974,433 38,192,419 37,973,848

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Basic and diluted

loss per share (0.16) (0.16) (0.32) (0.25)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Consolidated Statement of Cash Flows (unaudited)

Three Months Three Months Six Months Six Months

Ended March Ended March Ended March Ended March

31, 2008 31, 2007 31, 2008 31, 2007

$ $ $ $

OPERATING ACTIVITIES

Net loss and other

comprehensive

loss for the

period (6,063,584) (6,026,043) (12,179,267) (9,564,607)

Items not

affecting cash

Stock-based

compensation

expense 509,498 395,934 1,036,957 769,756

Interest

capitalized on

long-term debt - 571,013 - 1,140,355

Amortization of

intellectual

property 64,275 514,265 127,502 974,417

Amortization of

consoles at

customers' premises 221,747 269,474 440,470 478,312

Amortization of

property, plant,

and equipment 401,844 438,399 793,478 646,407

Amortization of

deferred financing

charges 102,427 118,705 205,888 258,698

Unrealized (gain)


'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
2. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
3. CryoCath Introduces Arctic Front in Australia
4. CryoCath Appoints New Chief Financial Officer
5. CryoCath Technologies notice of annual meeting
6. CryoCath Announces Fiscal 2008 First Quarter Results
7. CryoCath Provides Update on Patent Infringement Lawsuit
8. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
9. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
10. CryoCath announces 2007 fourth quarter and fiscal year end financial results
11. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...24 /PRNewswire/ -- MediVoice(R), LLC, the,world,s ...h and,e-Prescribing, has formed a strategic partne...teractive, web-based, patient-centered health reco...o integrate and market its,mobile voice-activation...OC) system., "MediVoice is pleased to develop a s...
(Date:7/23/2008)...wswire/ -- Philip J. Dwyer, president and CEO,of t...ny before the U.S.,Senate Health, Education, Labor... and Families today to call for increased funds fo...nted at YMCAs across the nation, that will,help re...e on behalf of the more than 2,600 YMCAs, that -- ...
(Date:7/23/2008)...migration and Naturalization ready at Passport ...uly 23 /PRNewswire/ -- New vaccine requirements wi...visa for entry into the U.S. and,anyone seeking ad...ants,must show proof of vaccinations against vacci.... Advisory Committee on Immunization Practices.,Pa...
(Date:7/23/2008)...008) Biodiversity has long been recognized by EPA ...rely on healthy ecosystems to provide food, clean ...he connection between disease and biodiversity (th...n a geographic region). Recent studies suggest th... diseases such as Lyme disease and West Nile encep...
Breaking Medicine News(10 mins):Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2Health News:Could preserving biodiversity reduce disease? 2
...ow dietary recommendations contained in tools like... been deveoped by researchers at the University of...erence to the recommendations decreases as the chi...of the study were to develop and test the potentia...
...icide permethrin can reduce the chances of malaria... conclusion was arrived at after Elizabeth Kimani ...er in Nairobi and other researchers studied Somali... in Kenya. The average household size in Kenya i...
...till fresh in the memory. There are a whole lot of...dequate measure’ is considered extremely crucial./... has extended this sentiment in evolving suitable ... onslaught. In the following week, Thai and Germa...
...wel complaint, now faces the risk of losing his le...l. // His left foot became infected when he was be...e was sent home, but returned four months later on... "I've been told I'm on the point of losing my le...
Other Medicine News:Health News:Adherence to Dietary Recommendations Measured 2Health News:Adherence to Dietary Recommendations Measured 3
(Date:7/21/2008)...on use of Zevalin as consolidation therapy after ...ts with follicular ... -- Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA:...led,a meeting with the U.S. Food and Drug Administ...ty of filing a supplemental Biologics License,Appl...
(Date:7/21/2008)...wire/ -- The SEAS (Simvastatin and Ezetimibe in,Ao...of intensive,cholesterol lowering with the combina...0 mg daily) in patients with aortic stenosis., Ao...the aortic valve in,the heart) is a relatively com...ons. Left untreated, it can progress to death from...
(Date:7/21/2008)...is a Must for Clinical Trials Management, WASHING...ation of,Academic Health Centers (AAHC) today laun...designed to assist academic health center leaders,...icers in establishing,strengthening, and improvin...ch enterprise, particularly to manage and support ...
(Date:7/21/2008)...ewswire/ -- Bioimpedance spectroscopy (BIS) is,mor...linical assessment of,lymphedema in breast cancer ...ly 20 issue of Journal of Clinical Oncology (2008;...ema After Breast Cancer: Incidence, Risk Factors, ...hored by Sandra Hayes, PhD.,and colleagues from Q...
Breaking Medicine Technology:CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4New AAHC Toolkit Available to Optimize Clinical Research Administration 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 1168 1Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 1168 2Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 1Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 2Thermo Fisher Scientific Acquires Leader in Micro Volume Spectrophotometers NanoDrop Technologies 1166 3SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT 40776 for the Treatment of Overactive Bladder 1164 1SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT 40776 for the Treatment of Overactive Bladder 1164 2Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 1Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 2Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 3Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 4Surgeons Develop Innovative Life Saving Treatments to Correct Massive Bleeding in Trauma Patients 477 5
... 05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc. t...linical study of novel monoclonal antibodies again...trate that NTB-A is a,potential new target for imm...ia and lymphomas. The study, entitled "The lymphoi...antibody target for,leukemia and lymphoma therapeu...
...SS WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX:...ng,oral spray formulations for a broad range of ma...inical studies comparing zolpidem,oral spray with ...netic (PK), pharmacodynamic (PD) and safety object...mbien(R), a leading,drug for the treatment of inso...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
...nstruments are designed to provide distraction of ...ate preparation, and insertion of interbody grafts... Intradiscal Wedges, Spanners, Nerve Root Retracto...(Anterior Thoracic Interbody Fusions), TLIF, PLIF,...
...let Concentrate System is a point-of-care system d...entrate (also referred to as Platelet Rich Plasma ... sample of blood. The Symphony II PCS concentrates...d in the platelets. The platelet concentrate can b...
...et gel has an extensive base of experience and kno... concentrated autologous platelets are mixed with ...tional changes involved in coagulation take place....rs including serotonin, fibronectin, adenosine dip...
The Leica 2D video system offers you two smart solutions for microsurgical video imaging. The Leica 2D pick-up system, an integrated camera module to fit on all Leica M-series and the Leica 2D C-moun
Medicine Products: